Mass spectrometry is a sensitive technique used to detect, identify and quantify molecules based on the ion-charge ratio.
Because of its sensitivity in these techniques, mass spectrometry emerged as a powerful tool for testing in many biopharmaceutical industries and research organizations.
Mass spectrometry is used in drug testing/ drug discovery, food contamination detection, pesticide residue analysis, isotope ratio determination, protein identification, and carbon dating.
Latest innovative technologies in mass spectrometry such as mobility spectrometry and capillary electrophoresis are being used in the separation of complex mixtures such as derived peptide products. Recent developments in the field of miniaturizations of mass spectrometers offer the potential of sampling in the emergence department and at the ICU bedside.
The global mass spectrometry market was worth XX billion in 2018 and is forecasted to reach XX billion by 2026, at a CAGR of XX% during the forecast period.
Increase in usage of mass spectrometry in proteomics, metabolomics, hospitals and pharmaceutical sectors for drug discovery and growing trends in miniaturization of spectrometers are driving the global mass spectrometry market.
Increase in spendings by pharmaceutical companies for R&D of emerging biosimilars, phytopharmaceuticals and regenerative medicine this is additionally creating demand for analytical equipment such as mass spectrometers and growing regulations for drug safety are amplifying the growth of the market.
Increase in reliance on personalized medicine, mass spectrometers have an immense ability to improvise clinical decisions making through the measurements of biomarkers that may not be detectable by alternative methods. Clinical integration of Mass spectrometry is being enhanced through the developments of instruments intended to use in Point of Care.
In May 2018, researchers at Purdue University had pioneered the development of “mini mass spec” (miniature mass spetcrometer) producing that instrument that can be carried by a handle and used in any location.
Major factors hindering the global mass spectrometry market are a high initial cost for equipment purchase and facilities required to establish and operate creating a financial burden on the hospitals or healthcare system and unavailability of skilled technicians in operating the equipment.
Global Mass Spectrometry market is segmented by product type and application type.
Product type includes liquid chromatography spectrometer, gas chromatography spectrometer, tandem mass spectrometer, matrix-assisted laser desorption ionization time-of-flight, ion-mobility mass spectrometry, and others.
By application, type includes forensic toxicology, proteomics research, diagnostics, pharma/biopharma, clinical research, and others.
Liquid chromatography spectrometer dominates the global mass spectrometry market during the forecast period due to rise in the number of medium and small companies are initiating in the field of life science research and the rapid surge in adoption of liquid chromatography-mass spectrometry in the clinical laboratories to reduce the processing time.
The higher accuracy and greater competency of Liquid chromatography technique over the gas chromatography-mass spectrometer technique and capital intensive nature led the pharmaceutical companies to adopt this technique.
The global mass spectrometry market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.
North America dominates the global mass spectrometry market due to the presence of advanced technologies and favorable government funding for the proteomic research that uses the mass spectrometry and non-government funding for advanced mass spectrometer and rise in biopharmaceutical and biotechnological R&D funding for innovative based research and expected to remain high during the forecast period.
In January 2019, National Institute of Health funded University of Georgia researchers with 1.956 million for development of high-resolution mass spectrometer.
New product launches in Mass Spectrometers using advanced technology and mergers or strategic collaborations between key players in developing the spectrometers for a specific purpose are driving the global mass spectrometry market.
In January 2019, Shimadzu Corporation launched a mass spectrometer with a probe electrospray ionization unit for quick detection of Pharmalogical agents and Metabolites.
In January 2019, Biodesix and MRM Proteomics merged to develop mass spectroscopy based tests for lung cancer.
In November 2018, PerkinElmer introduced QSight 400 Series Triple Quad Mass Spectrometer at MJBizCon 2018.
In September 2018, ThermoFisher Scientific launched New Single Quadrupole Spectrometry technology designed for Chromatographers Performing LC-MS Routine Analysis.
In August 2018, JOEL expands the lineup of gas chromatography-mass spectrometry by releasing new triple quadrupole mass spectrometer “JMS-TQ4000GC”.
In June 2017, Shimadzu and Phytronix have signed an agreement to offer the industry’s first Triple Ion Source.
In July 2017, waters corporation an analytical laboratory instrument manufacturing company obtained the nonexclusive license from SISCAPA Assay Technologies, Inc. (SAT) for the standardization of liquid chromatography/ mass spectrometry assays.
Major market players in the Mass Spectrometry market are Waters Corporation, Sciex, Bruker, Joel, Shimadzu Corporation, PerkinElmer, Analytik Jena, Thermo Fisher Scientific, Leco, and Others.
Equipment Suppliers/ Buyers
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
1.1. Research Methodology
1.2. The Scope of the market
3.5. Supply Chain Analysis
3.6. Reimbursement policies
3.7. Technological Advancements
3.8. Porter’s Five Forces Analysis
4.1. By Product Type
4.1.1. Liquid Chromatography Spectrometer
4.1.2. Gas chromatography Spectrometer
4.1.3. Tandem Mass Spectrometer
4.1.4. Matrix- Assisted Laser Desorption Ionization Time-Of-Flight
4.1.5. Ion-Mobility Mass Spectrometry
4.2. By Application
4.2.1. Forensic Toxicology
4.2.2. Proteomics Research
4.2.4. Clinical Research
5.1. Geographic Overview
5.2. North America
5.2.1. The U.S.
5.3.2. The U.K.
5.3.6. Rest of Europe
5.4. South America
5.4.3. Rest of South America
5.5. Asia Pacific
5.5.5. Rest of Asia Pacific
5.6. Rest of World
6.1. Competitive Scenario
6.2. Heat Map Analysis
6.3. Product Benchmarking
7.1. Waters Corporation
7.5. Shimadzu Corporation
7.6. Perkin Elmer
7.7. Analytik Jena
7.8. Thermo Fisher Scientific
10.2. List of Tables
10.3. Expert Panel Validation
10.5. Contact Us
Get your FREE SAMPLE PROPOSAL with a single click!